Hostname: page-component-6766d58669-rxg44 Total loading time: 0 Render date: 2026-05-21T04:51:06.990Z Has data issue: false hasContentIssue false

The otological status of patients with nasopharyngeal carcinoma after megavoltage radiotherapy

Published online by Cambridge University Press:  29 June 2007

Nelson L. S. Tang
Affiliation:
Hong Kong
Alexander T. K. Choy
Affiliation:
Hong Kong
D. Gareth John
Affiliation:
Hong Kong
C. A. van Hasselt*
Affiliation:
Hong Kong
*
C. A. van Hasselt, Division of Otorhinolaryngology, Department of Surgery, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong. Fax: (852 6466312)

Abstract

A middle ear effusion is a common complication of nasopharyngeal carcinoma both before and after radiotherapy. An effusion was found in 38 per cent of patients before radiotherapy and 9 per cent developed an effusion after the start of radiotherapy. Surgical treatment by myringotomy with or without grommet insertion was associated with a high incidence of otorrhoea (26 per cent) which was often refractory to treatment. In view of the frequency of this complication and the fact that a middle ear effusion may not be of concern to an adult patient with nasopharyngeal carcinoma, a ‘wait and see’ policy may be appropriate in the management of a middle ear effusion in these patients.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable